KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Travere Therapeutics (TVTX) Inventory Average (2016 - 2025)

Travere Therapeutics' Inventory Average history spans 12 years, with the latest figure at $5.7 million for Q4 2025.

  • For Q4 2025, Inventory Average fell 9.02% year-over-year to $5.7 million; the TTM value through Dec 2025 reached $5.7 million, down 9.02%, while the annual FY2025 figure was $6.0 million, 22.65% down from the prior year.
  • Inventory Average reached $5.7 million in Q4 2025 per TVTX's latest filing, up from $4.8 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $19.8 million in Q3 2023 to a low of $4.0 million in Q2 2025.
  • Average Inventory Average over 5 years is $7.7 million, with a median of $6.9 million recorded in 2021.
  • Peak YoY movement for Inventory Average: skyrocketed 164.84% in 2023, then tumbled 68.81% in 2024.
  • A 5-year view of Inventory Average shows it stood at $7.0 million in 2021, then dropped by 15.14% to $5.9 million in 2022, then soared by 155.36% to $15.1 million in 2023, then tumbled by 58.4% to $6.3 million in 2024, then decreased by 9.02% to $5.7 million in 2025.
  • Per Business Quant, the three most recent readings for TVTX's Inventory Average are $5.7 million (Q4 2025), $4.8 million (Q3 2025), and $4.0 million (Q2 2025).